Objectives: The aim of this study was to determine whether left ventricular (LV) midwall
fibrosis, detected by midwall hyperenhancement (MWHE) on late gadolinium enhancement …

Objectives: We studied the prognostic implications of midwall fibrosis in dilated
cardiomyopathy (DCM) in a prospective longitudinal study. Background: Risk stratification of …

Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …

Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is
primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may …

Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

Background Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated
cardiomyopathy (NIDC) relies on left ventricular (LV) dysfunction, a poor marker of …

Background The presence of myocardial fibrosis is associated with worse clinical outcomes
in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR) with late …

Aims To determine whether the extent of myocardial fibrosis by late-gadolinium
enhancement cardiovascular magnetic resonance (LGE-CMR), and echocardiographic …

Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Background—We conducted a prospective longitudinal study to investigate the yet unknown
clinical significance of myocardial fibrosis in patients with non–ischemic cardiomyopathy …